RecruitingNCT05649007

Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery


Sponsor

Gruppo Bioimpianti S.r.l.

Enrollment

630 participants

Start Date

Sep 30, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Post-market clinical follow up investigation on the use of saphir stem and FIN Cup or Dualis system in the treatment of pathologies requiring hip arthroplasty. The main object of the clinical investigation is the evaluation of long term survival rate of Saphir stem.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • patients\>18 years
  • Candidate for primary total hip replacement with femoral stem and acetabular cup
  • if ostheoarthritis patients aged 18 to 85 years
  • if femoral neck fracture patients aged 18 to 90 years
  • patients with social security scheme
  • patients understands the condition of the study and is willing to partecipate for the duration of the clinical investigation
  • patients who gavee consent to partecipare in the clinical investigation

Exclusion Criteria9

  • \<18 years
  • if female, pregnant
  • patient who has already had primary hip surgery on the same side
  • local or disseminated neoplastic disease
  • inability to understand the study and agree to partecipate
  • patients cancelling partecipation before surgery
  • patients under guardianship or curatorship
  • patients without a social security scheme
  • patients refusing to partecipate

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEhip arthroplasty with prosthesis

Use of femoral stem and acetabular cup for hip arthroplasty


Locations(1)

Hopital Ducuing

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05649007


Related Trials